Hidetoshi Seki

1.2k total citations
30 papers, 1.0k citations indexed

About

Hidetoshi Seki is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Hidetoshi Seki has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Hidetoshi Seki's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (4 papers). Hidetoshi Seki is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (4 papers). Hidetoshi Seki collaborates with scholars based in Japan, United States and Australia. Hidetoshi Seki's co-authors include Akihiro Yachie, Yoshihito Kasahara, Naoyuki Taniguchi, Toshio Miyawaki, Kunio Ohta, Akihiro Konno, Kazuyuki Iwai, Shoichi Koizumi, Tomoko Toma and Kazuhide Ohta and has published in prestigious journals such as Blood, The Journal of Immunology and Kidney International.

In The Last Decade

Hidetoshi Seki

28 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetoshi Seki Japan 16 456 393 153 126 123 30 1.0k
C. Vincent France 18 272 0.6× 285 0.7× 121 0.8× 86 0.7× 113 0.9× 63 1.1k
J.L. Touraine France 20 938 2.1× 321 0.8× 190 1.2× 54 0.4× 213 1.7× 106 1.8k
Elisabeth Maier Austria 15 410 0.9× 236 0.6× 191 1.2× 86 0.7× 112 0.9× 29 1.1k
Gaëlle Bériou France 21 1.3k 2.9× 524 1.3× 201 1.3× 127 1.0× 99 0.8× 31 1.9k
W G Reeves United Kingdom 23 363 0.8× 404 1.0× 62 0.4× 74 0.6× 123 1.0× 59 1.4k
B. Ryffel Switzerland 19 517 1.1× 354 0.9× 167 1.1× 29 0.2× 119 1.0× 36 1.2k
Kunio Ohta Japan 21 806 1.8× 578 1.5× 172 1.1× 63 0.5× 279 2.3× 51 1.7k
L A Boxer United States 21 595 1.3× 392 1.0× 148 1.0× 39 0.3× 102 0.8× 36 1.4k
Panayiotis Victoratos Greece 11 339 0.7× 240 0.6× 103 0.7× 57 0.5× 99 0.8× 11 711
B Zanker Germany 17 448 1.0× 195 0.5× 202 1.3× 28 0.2× 202 1.6× 48 1.3k

Countries citing papers authored by Hidetoshi Seki

Since Specialization
Citations

This map shows the geographic impact of Hidetoshi Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Seki more than expected).

Fields of papers citing papers by Hidetoshi Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Seki. The network helps show where Hidetoshi Seki may publish in the future.

Co-authorship network of co-authors of Hidetoshi Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Seki. A scholar is included among the top collaborators of Hidetoshi Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Seki. Hidetoshi Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niida, Yo, et al.. (2013). [The association of hypocarnitinemia with enteral diets and antiepileptic drugs in children and adults with severe physical and mental disabilities].. PubMed. 45(6). 445–50. 1 indexed citations
2.
Shimizu, Masaki, Kazuhide Ohta, Yonghong Yang, et al.. (2005). Glomerular Proteinuria Induces Heme Oxygenase-1 Gene Expression within Renal Epithelial Cells. Pediatric Research. 58(4). 666–671. 20 indexed citations
3.
Kaneko, Hideo, Toshiyuki Fukao, Eiko Matsui, et al.. (2004). Relatively common mutations of the Bloom syndrome gene in the Japanese population. International Journal of Molecular Medicine. 14(3). 439–42. 5 indexed citations
4.
Yang, Yonghong, Kazuhide Ohta, Masaki Shimizu, et al.. (2003). Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury. Kidney International. 64(4). 1302–1309. 39 indexed citations
5.
Yachie, Akihiro, Yonghong Yang, Masaki Shimizu, et al.. (2001). Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Kidney International. 60(5). 1858–1866. 91 indexed citations
6.
Ohta, Kazuhide, Akihiro Yachie, Hisashi Kaneda, et al.. (2000). Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. American Journal of Kidney Diseases. 35(5). 863–870. 94 indexed citations
7.
Wada, Taizo, Tomoko Toma, Yoshihito Kasahara, et al.. (1999). Age-Dependent Increase of IgE-Binding and FcεRI Expression on Circulating Basophils in Children. Pediatric Research. 46(5). 603–603. 6 indexed citations
8.
Seki, Hidetoshi, Yoshihito Kasahara, Kunio Ohta, et al.. (1999). Antimicrobial activities of cefditoren against respiratory pathogens isolated from children in Japan. Journal of Infection and Chemotherapy. 5(1). 16–20. 7 indexed citations
9.
Seki, Hidetoshi, Yoshihito Kasahara, Kunio Ohta, et al.. (1999). Increasing Prevalence of Ampicillin- Resistant, Non-Beta-Lactamase-Producing Strains of <i>Haemophilus influenzae</i> in Children in Japan. Chemotherapy. 45(1). 15–21. 54 indexed citations
10.
Wada, Hideo, Hiroyuki Akiyama, Hidetoshi Seki, et al.. (1998). Spinal Canal Involvement in Infantile Myofibromatosis. Journal of Pediatric Hematology/Oncology. 20(4). 353–356. 17 indexed citations
11.
Kanegane, Hirokazu, Kishor Bhatia, Marina Gutiérrez, et al.. (1998). A Syndrome of Peripheral Blood T-Cell Infection With Epstein-Barr Virus (EBV) Followed by EBV–Positive T-Cell Lymphoma. Blood. 91(6). 2085–2091. 6 indexed citations
12.
Kanegane, Hirokazu, Kishor Bhatia, Marina Gutiérrez, et al.. (1998). A Syndrome of Peripheral Blood T-Cell Infection With Epstein-Barr Virus (EBV) Followed by EBV–Positive T-Cell Lymphoma. Blood. 91(6). 2085–2091. 88 indexed citations
13.
Kanegane, Hirokazu, et al.. (1996). Chronic persistent Epstein‐Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion. British Journal of Haematology. 95(1). 116–122. 25 indexed citations
14.
Kanegane, Hirokazu, et al.. (1994). Kawasaki disease with a concomitant primary Epstein‐Barr virus infection. Pediatrics International. 36(6). 713–716. 18 indexed citations
15.
Yachie, Akihiro, et al.. (1993). Toxic shock syndrome associated with induction chemotherapy for acute myelocytic leukemia: Measurement of acute phase serum cytokine levels.. Japanese Journal of Clinical Immunology. 16(5). 376–382.
16.
Nanno, Masanobu, Hidetoshi Seki, Kyogo Itoh, et al.. (1992). γ/δ T cell antigen receptors expressed on tumor‐infiltrating lymphocytes from patients with solid tumors. European Journal of Immunology. 22(3). 679–687. 36 indexed citations
17.
Platsoucas, Chris D., et al.. (1990). Purine nucleoside modulation of functions of human lymphocytes. Cellular Immunology. 129(2). 321–328. 22 indexed citations
19.
Miyawaki, Toshio, Hidetoshi Seki, K Taga, & Naoyuki Taniguchi. (1984). Interferon-γ can augment expression ability of HLA-DR antigens on pokeweed mitogen-stimulated human T lymphocytes. Cellular Immunology. 89(2). 300–309. 9 indexed citations
20.
Uchigata, Yasuko, et al.. (1982). A CASE OF MOSQUITO HYPERSENSITIVITY TERMINATING AS MALIGNANT HISTIOCYTOSIS. The Journal of Dermatology. 9(6). 437–443. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026